Christian Rommel became Executive Vice President, Global Head of Research & Development and a member of the executive committee of Bayer Pharmaceuticals in February 2021. Before joining Bayer, he was working as Senior Vice President, Global Head of Oncology, Pharma Research and Early Development (pRED) at Roche. Before that, He worked at Amgen as a Vice President of External Research and Development and Vice President, Research Oncology. He also served as Chief Scientific Officer of Intellikine from its inception to acquisition by Takeda. His prior positions also include leadership as well as scientist roles at Merck Serono and Regeneron. He was also a lecturer of biotechnology at the ETH Zurich, Switzerland.

Christian Rommel received his PhD in molecular oncology from the Max Planck Institute in Berlin, Germany and the Institute of Medical Virology at the University of Zurich, Switzerland. He has authored more than 70 publications, including papers in Science and Nature, and is an inventor or co-inventor of 18 patents.